|
시장보고서
상품코드
2049774
인지 능력 및 기억력 개선제 시장 보고서 : 제품별, 용도별, 지역별(2026-2034년)Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2026-2034 |
||||||
세계의 인지 능력·기억력 개선제 시장 규모는 2025년에 64억 7,160만 달러에 달했습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 4.48%로 추이하며, 2034년까지 97억 1,550만 달러에 달할 것으로 예측하고 있습니다. 인지장애 유병률의 증가, 새로운 화합물 및 제제 개발을 위한 연구개발 활동의 활성화, 그리고 새로운 약물 및 혁신적인 약물전달 방법의 도입 등이 시장을 촉진하는 주요 요인으로 작용하고 있습니다.
인지기능 및 기억력 향상제(노오트로픽 또는 스마트 약물이라고도 함)는 기억력, 주의력, 창의력 및 전반적인 정신 능력과 같은 인지기능을 향상시키는 것을 목표로 합니다. 이 약물들은 뇌의 활동을 증가시키고 더 나은 인지 능력을 촉진하도록 설계되었습니다. 특정 질환에 대해는 처방전이 필요하지만, 일반의약품으로 구입하거나 온라인을 통해 구입할 수도 있습니다. 이들은 뇌내 특정 신경전달물질의 분비를 증가시켜 각성도와 집중력을 높여줍니다. 또한 기억력과 학습에 중요한 아세틸콜린 수치를 높이는 효과도 있습니다. 항산화 및 항염증약로 작용하여 뇌를 손상으로부터 보호하고 최적의 뇌 기능을 촉진합니다. 또한 생각을 명료하게 하고, 인지 처리 속도를 향상시켜 의사결정 능력을 향상시킵니다. 단기기억과 장기기억을 개선하고, 정보를 쉽게 기억하고 유지할 수 있도록 도와줍니다. 또한 생산성, 효율성, 인지 능력을 향상시켜 학업 및 업무 수행 능력 향상에 기여합니다.
인지기능-기억력 향상제 시장 동향:
현재 알츠하이머병, 치매, 주의력결핍 및 과잉행동장애(ADHD) 등 인지장애의 유병률 증가가 시장 성장을 지원하는 주요 요인 중 하나입니다. 이와 더불어, 사람들은 뇌 건강을 적극적으로 관리하고 인지 능력을 향상시킬 수 있는 방법을 모색하고 있으며, 이는 인지 능력 및 기억력 향상 약물에 대한 수요를 촉진하고 있습니다. 또한 인지기능과 기억력을 향상시킬 수 있는 새로운 화합물 및 제제를 찾기 위한 연구개발(R&D) 활동이 활발해지면서 시장 성장을 촉진하고 있습니다. 이에 따라 새로운 의약품과 혁신적인 약물전달 방법의 개발이 진행되어 소비자가 이용할 수 있는 선택의 폭이 넓어지고 있는 것도 시장 성장을 더욱 견고하게 하고 있습니다. 또한 고령화가 진행됨에 따라 노화에 따른 인지기능 저하와 기억력 감퇴를 완화할 수 있는 약물에 대한 수요가 증가하고 있는 것도 시장에 긍정적인 전망을 가져다주고 있습니다. 이와 더불어 학업 및 업무 성과 향상을 원하는 학생과 전문가들 사이에서 인지기능 및 기억력 향상 약물의 채택이 증가함에 따라 업계 투자자들에게 매력적인 성장 기회를 제공하고 있습니다. 또한 온라인 및 오프라인 판매 채널을 통해 인지기능 및 기억력 개선제가 널리 보급되고 있는 것도 시장 성장에 기여하고 있습니다.
이 보고서에서 답변하는 주요 질문
- 세계 인지기능 및 기억력 개선제 시장은 지금까지 어떤 추세를 보여 왔으며, 향후 수년간 어떤 추세를 보이는가?
- 세계의 인지기능 및 기억력 개선제 시장 촉진요인, 억제요인 및 기회는 무엇인가?
- 각 촉진요인, 제약 요인 및 기회는 글로벌 인지기능 및 기억력 향상제 시장에 어떤 영향을 미치고 있는가?
- 주요 지역 시장은 어디인가?
- 가장 매력적인 인지기능 및 기억력 개선제 시장을 형성하고 있는 국가는 어디인가?
- 제품별로 보면 시장 분석은 어떻게 이루어지는가?
- 인지기능-기억력 개선제 시장에서 가장 매력적인 제품은 무엇인가?
- 용도별 시장 현황은?
- 인지기능 및 기억력 개선제 시장에서 가장 매력적인 용도는 무엇인가?
- 세계의 인지기능 및 기억력 개선제 시장의 경쟁 구조는 어떠한가?
- 세계의 인지기능 및 기억력 개선제 시장의 주요 플레이어/기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 인지 능력·기억력 개선제 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 지역별
제9장 촉진요인·억제요인·기회
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSA 26.06.11The global cognitive and memory enhancer drugs market size reached USD 6,471.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 9,715.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.48% during 2026-2034. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.
Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.
COGNITIVE AND MEMORY ENHANCER DRUGS MARKET TRENDS:
At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.
KEY MARKET SEGMENTATION:
Product Insights:
- Aricept
- Exelon
- Namenda
- Razadyne
- Provigil
- Ritalin
- Adderall
- Others
Application Insights:
- Disease Treatment
- Athletic Performance
- Academic Performance
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
- What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
- What are the key regional markets?
- Which countries represent the most attractive cognitive and memory enhancer drugs market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the cognitive and memory enhancer drugs market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the cognitive and memory enhancer drugs market?
- What is the competitive structure of the global cognitive and memory enhancer drugs market?
- Who are the key players/companies in the global cognitive and memory enhancer drugs market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cognitive and Memory Enhancer Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Aricept
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Exelon
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Namenda
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Razadyne
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Provigil
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Ritalin
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Adderall
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Application
- 7.1 Disease Treatment
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Athletic Performance
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Academic Performance
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 AbbVie Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Eisai Co Ltd.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Novartis AG
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Takeda Pharmaceutical Company Ltd.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.1 AbbVie Inc.
